88 Photos and videos
Pinned Tweet
23 Feb 2021
ICYMI: PR Newswire has rolled out a free, fully customizable #healthcare focused newsfeed. The newsfeed will feature releases on your site, not redirect traffic. Learn more here: prn.to/2ZGzwsD #health #content
1
7 Jan 2025
Zydus announces agreement with CVS Caremark to add Zituvio™, Zituvimet™ and Zituvimet™ XR (Sitagliptin | Sitagliptin and Metformin Hydrochloride) to its template formulary prnewswire.com/news-releases…
23
7 Jan 2025
Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment prnewswire.com/news-releases…
13
2 Dec 2024
$RDHL awarded $8 million plus costs in New York Supreme Court summary judgment against Kukbo. #RDHL prnewswire.com/il/news-relea…
11
20 Nov 2024
Meril Champions Innovation with Myval Octapro THV Launch at GISE 2024 & PCR LondonValves 2024 prnewswire.co.uk/news-releas…
1
1
110
12 Nov 2024
New Ipsos global survey shines a light on the myopia epidemic prnewswire.co.uk/news-releas…
10
23 Oct 2024
#RDHL & @DukeMedSchool to develop #opaganib as a medical #countermeasure for phosgene injury, aimed toward advanced U.S. government-sponsored #FDA Animal Rule development. $RDHL PR: prnewswire.com/il/news-relea…
41
3 Oct 2024
Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries prnewswire.com/news-releases…
32
30 Sep 2024
#RDHL #opaganib granted new @USPTO patent for identification of a novel biomarker of coronavirus pneumonia - prognostic for potential opaganib efficacy in treating COVID-19, valid through 2041. $RDHL PR: prnewswire.com/news-releases…
28
13 Sep 2024
Zydus announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable, contrast agents in the US prnewswire.com/news-releases…
17
9 Sep 2024
#RDHL’s #Talicia, positioned first-line for the treatment of # HPylori infection in the new @AmCollegeGastro clinical guideline. Read the $RDHL PR: prnewswire.com/news-releases…
15
4 Sep 2024
Exciting Developments in Clinical Research: Axcellant's Groundbreaking Global Study prnewswire.com/news-releases…
8
27 Aug 2024
#RDHL #opaganib granted @US_FDA #orphandrug status for #neuroblastoma, the most common #infant #malignancy accounting for 15% of #pediatric #cancer deaths. Broad #oncology potential & 7-years exclusivity. $RDHL PR: bit.ly/3XjmboE #FDA
39
1 Aug 2024
New publication in @antibioticsmdpi of ground-breaking positive data from #RDHL’s Phase 3 Crohn’s study shows #RHB-104 standard of care (SoC) was 64% more effective than SoC alone. Primary endpoint met with high statistical significance $RDHL PR: bit.ly/3SwGn3U#Antibiotics
29
9 Jul 2024
YewMaker - New Playbook Launches to Tackle Global Challenge of Wasted Medicines prnewswire.com/news-releases…
8
8 Apr 2024
$RDHL 2023 results: “RedHill is transformed - focused on predominantly U.S. government-funded pipeline development in underserved, sizeable therapeutic areas with a disciplined cost-base & unburdened by debt, with a clear value proposition”. #RDHL PR: prnewswire.com/news-releases…
11
2 Apr 2024
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price prnewswire.com/news-releases…
8
25 Jan 2024
RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042 prnewswire.com/news-releases…
69
22 Jan 2024
Response Plus Medical announces strategic acquisition of UK-based Prometheus as part of global expansion plans prnewswire.co.uk/news-releas…
48
17 Jan 2024
Oxford Medical Simulation Raises $12.6 Million in Series A Funding to Address Critical Healthcare Training Gap with Virtual Reality prnewswire.com/news-releases…
27
8 Jan 2024
JBI-802 initial Phase I data suggests therapeutic potential in sensitizing immunotherapy resistant tumors and in Myeloproliferative Neoplasms with thrombocytosis prnewswire.com/news-releases…
15